Article info
Cancer genetics
Original article
Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies
- Correspondence to Professor D G R Evans, Consultant Clinical Geneticist, Manchester Centre for Genomic Medicine, MAHSC, St. Mary's Hospital, Oxford Road, Manchester M13 9WL, UK; gareth.evans{at}cmft.nhs.uk
Citation
Long-term prospective clinical follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in adjusted retrospective studies
Publication history
- Received February 4, 2014
- Revised July 1, 2014
- Accepted July 2, 2014
- First published July 22, 2014.
Online issue publication
August 12, 2014
Article Versions
- Previous version (22 July 2014).
- Previous version (28 July 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions